Market closedNon-fractional
Axonics Modulation Technologies/AXNX
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Axonics Modulation Technologies
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Ticker
AXNX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Irvine, United States
Employees
797
Website
www.axonics.com
AXNX Metrics
BasicAdvanced
$3.4B
Market cap
-
P/E ratio
-$0.32
EPS
0.59
Beta
-
Dividend rate
Price and volume
Market cap
$3.4B
Beta
0.59
Financial strength
Current ratio
9.962
Quick ratio
7.922
Long term debt to equity
4.808
Total debt to equity
5.041
Interest coverage (TTM)
-126.51%
Management effectiveness
Return on assets (TTM)
-0.68%
Return on equity (TTM)
-2.65%
Valuation
Price to revenue (TTM)
8.66
Price to book
5.5
Price to tangible book (TTM)
7.66
Price to free cash flow (TTM)
-205.92
Growth
Revenue change (TTM)
30.82%
Earnings per share change (TTM)
-67.07%
3-year revenue growth
47.92%
3-year earnings per share growth
-41.84%
What the Analysts think about AXNX
Analyst Ratings
Majority rating from 14 analysts.
AXNX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$91M
-16.68%
Net income
-$19M
-393.85%
Profit margin
-20.89%
-452.87%
AXNX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.15
$0.08
$0.13
-$0.38
-
Expected
-$0.11
-$0.06
$0.06
-$0.08
$0.13
Surprise
32.00%
-245.45%
123.37%
352.38%
-
AXNX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Axonics Modulation Technologies stock?
Axonics Modulation Technologies (AXNX) has a market cap of $3.4B as of July 04, 2024.
What is the P/E ratio for Axonics Modulation Technologies stock?
The price to earnings (P/E) ratio for Axonics Modulation Technologies (AXNX) stock is 0 as of July 04, 2024.
Does Axonics Modulation Technologies stock pay dividends?
No, Axonics Modulation Technologies (AXNX) stock does not pay dividends to its shareholders as of July 04, 2024.
When is the next Axonics Modulation Technologies dividend payment date?
Axonics Modulation Technologies (AXNX) stock does not pay dividends to its shareholders.
What is the beta indicator for Axonics Modulation Technologies?
Axonics Modulation Technologies (AXNX) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
![Buy or sell Axonics Modulation Technologies stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Axonics Modulation Technologies stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.